Showing results (2201-2210 of 2,460) with videos related to

Sort By:
Pageof 246
Journal of Alzheimer'S Disease : JAD|October 18, 2024
Varoglutamstat: Inhibiting Glutaminyl Cyclase as a Novel Target of Therapy in Early Alzheimer's DiseaseHoward H Feldman, Karen Messer, Yuqi Qiu, et al.
Medrxiv : the Preprint Server for Health Sciences|April 3, 2026
Anillin variant in proteinuric kidney disease drives tubular epithelial cell death, junctional instability, and barrier dysfunctionZie Craig, Holly M Jacobs, Damian Fermin, et al.
Plos One|May 29, 2024
Protocol for a seamless phase 2A-phase 2B randomized double-blind placebo-controlled trial to evaluate the safety and efficacy of benfotiamine in patients with early Alzheimer's disease (BenfoTeam)Howard H Feldman, José A Luchsinger, Gabriel C Léger, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 22, 2026
The EPS-I exopolysaccharide transforms Ralstonia wilt pathogen biofilms into viscoelastic fluids for rapid dissemination in plantaMatthew L Cope-Arguello, Jiayu Li, Zachary Konkel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 8, 2006
Vaccination of colorectal cancer patients with CEA-loaded dendritic cells: antigen-specific T cell responses in DTH skin testsW J Lesterhuis, I J M de Vries, D H Schuurhuis, et al.
Cancer|October 7, 2015
Identification of germline genetic mutations in patients with pancreatic cancerErin E Salo-Mullen, Eileen M O'Reilly, David P Kelsen, et al.
Journal of Virology|August 25, 2006
Integrated molecular signature of disease: analysis of influenza virus-infected macaques through functional genomics and proteomicsT Baas, C R Baskin, D L Diamond, et al.
IJTLD Open|November 17, 2025
High-dose amikacin in the first week of all-oral rifampicin-resistant TB treatment is safe: a single-arm trialJ Snobre, J Gasana, T Decroo, et al.
Metabolites|December 23, 2022
Flavor Profiling Using Comprehensive Mass Spectrometry Analysis of Metabolites in Tomato SoupsSimon Leygeber, Justus L Grossmann, Carmen Diez-Simon, et al.
Clinical Chemistry and Laboratory Medicine|January 2, 2026
Laboratory findings in patients treated with complement factor C3 inhibitor pegcetacoplanSaskia M C Langemeijer, Jeroen D Langereis, Mendy Ter Avest, et al.
Pageof 246